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Feline infectious peritonitis (FIP) is a well-known and widely distributed coronavirus 
(FCoV)-induced systemic disease in cats. It is characterised by fibrinous-granulomatous 
serositis with protein-rich effusions into body cavities, granulomatous phlebitis and 
periphlebitis, and granulomatous inflammatory lesions in several organs. The development of 
FIP lesions is triggered by activated, virus infected monocytes. Many systemic changes, 
including recurrent fever, are seen. These all indicate excessive cytokine release, the source of 
which has yet to be determined. This study investigated the possible contribution of the liver 
to the disease by examining it for the transcription and translation of relevant cytokines. A 
quantitative reverse transcriptase polymerase chain reaction (RT-qPCR) for the detection of 
feline interleukin-1β (IL-1β), IL-6, IL-10, IL-12p40, and tumour necrosis factor-α (TNF-α) 
was carried out on liver samples of naturally and experimentally infected cats with FIP, and 
FCoV-infected SPF cats without FIP. Cytokine transcription was detected in all groups, 
however mRNA levels were significantly higher for IL-6 in all cats with FIP; in those with 
naturally acquired FIP, all other cytokines were also upregulated. Immunohistology 
confirmed cytokine translation and identified the hepatocytes as the main source. These 
results show a potential contribution by hepatocytes to systemic effects such as fever and 
vasculitis in the development of FIP. 
 
























Die Feline Infektiöse Peritonitis (FIP) ist eine tödliche Coronavirus-induzierte Erkrankung der 
Katzen, die durchgranulomatöse Serositiden mit proteinreichen Ergüssen sowie 
granulomatöse (Peri)-Phlebitiden und Entzündungsprozessen in Organen charakterisiert ist. 
Entscheidend für die Erkrankung sind aktivierte, Virus-infizierte Monozyten.  Das Auftreten 
zahlreicher  systemische Veränderungen, wie rezidivierendes Fieber, aufspricht dafür, dass es 
ausserdem zu einer übermässigen Zytokinfreisetzung kommt; deren Quelle ist bisher jedoch 
nicht bekannt.    
Die vorliegende Arbeit hat den möglichen Beitrag der Leber (unabhängig vom Vorhandensein 
typischer FIP-Läsionen) am Krankheitsgeschehen untersucht.  Eine quantitative reverse 
Transkription-Polymerasekettenreaktion zum Nachweis von felinem Interleukin-1β (IL-1β), 
IL-6, IL-10, IL-12p40 und Tumornekrosefaktor-α (TNF-α)  an Leberproben von natürlich 
erkrankten und experimentell infizierten Katzen mit FIP sowie FCoV-infizierten SPF-Katzen 
ohne FIP. wies eine Transktiption dieser Zytokine in der Leber aller Tiere nach. Bei Katzen 
mit FIP war die IL-6-Transkription signifikant erhöht, bei den natürlich infizierten Tieren gilt 
dies auch für alle anderen Zytokine.  Mittels Immunhistologie wurde die Translation der 
Zytokine bestätigt und die Expression vor allem durch Hepatozyten nachgewiesen.  Diese 
Ergebnisse deuten darauf hin, dass die Leber bei der Entstehung der systemischen FIP-
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Feline infectious peritonitis (FIP) is a widespread and almost invariably fatal systemic 
disease of cats induced by feline coronavirus (FCoV). The classical lesions consist of 
pyogranulomatous-necrotising phlebitis and periphlebitis of multiple organs, often 
accompanied by protein-rich effusions into body cavities. The development of FIP lesions is 
triggered by activated, virus infected monocytes, whereas systemic changes such as recurrent 
fever indicate excessive systemic cytokine release, the source of which has yet to be determined. 
This study investigated the possible contribution of the liver to the disease by examining it for 
the transcription and translation of relevant cytokines. A quantitative reverse transcriptase 
polymerase chain reaction (qRT-PCR) for the detection of feline interleukin-1β (IL-1β), IL-6, 
IL-10, IL-12p40, and tumour necrosis factor-α (TNF-α) was carried out on liver samples of cats 
with FIP and FCoV-infected cats without FIP. Cytokine transcription was detected in both 
groups. However, mRNA levels were significantly higher in the cats with FIP. 
Immunohistology confirmed cytokine translation and identified hepatocytes as the main source. 
These results show a potential contribution by hepatocytes to systemic effects such as fever and 
vasculitis in the development of FIP. 
 







Feline infectious peritonitis (FIP) is a coronavirus-induced fatal systemic immune-mediated 
disease in cats, characterised by fibrinous-granulomatous serositis, often with protein-rich 
effusions into body cavities, granulomatous phlebitis and periphlebitis, and granulomatous 
inflammatory lesions in several organs (Hayashi et al., 1977; Weiss and Scott, 1981a; Kipar et 
al., 1998; Kipar et al., 2005). The disease presents clinically with recurrent fever and signs 
reflecting the distribution of organ lesions. The development of FIP lesions is triggered by 
activated, virus infected monocytes. These induce the hallmark of the disease, a granulomatous 
phlebitis that occurs in a range of organs (Kipar et al., 2005). When the granulomatous phlebitis 
is present, animals also exhibit generalised activation of venous endothelial cells which, 
together with other systemic changes such as fever, indicate excessive systemic cytokine release 
(Kipar et al., 2005; Dinarello, 2007).  
Pro-inflammatory cytokines are the main mediators of the innate immune response, allowing 
communication between and priming of the various components of the innate immune system, 
e.g. activation of leukocytes and endothelial cells (reviewed by Dinarello, 2007; Akdis et al., 
2011).  
IL-1, IL-6, and TNF-α are of particular relevance in the feline acute phase response 
(Paltrinieri, 2008). In FIP, their role does not appear consistent. Goitsuka et al. (1988, 1990) 
found high IL-6 and IL-1 activity in sera, ascitic fluid, and the supernatant of cultured peritoneal 
exudate cells. IL-6 mRNA levels in peripheral blood mononuclear cells (PBMC) were found to 
be unaltered, mildly increased or variable (Gunn-Moore et al., 1998; Kiss et al., 2004; Gelain 
et al., 2006), whilst IL-10 and IL-12 transcription was markedly depressed (Gunn-Moore et al., 
1998). In an experimental feline coronavirus (FCoV) vaccination study, IL-12, TNF-α, and, 
less intensely, IL-10 mRNA levels increased after challenge independent of the development 
of FIP (Kiss et al., 2004).  In contrast, a study on natural FIP cases found no elevation in serum 
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TNF-α and IL-1 transcription levels at the time of euthanasia (Gelain et al., 2006).  
More recent in vitro studies showed that virulent FCoV (i.e. FIPV)-infected macrophages 
produce TNF-α which in turn functions both as a possible contributor to lymphocyte apoptosis 
(observed in FIP (Haagmans et al., 1996; Kipar et al., 2001a)) and a stimulator of 
aminopeptidase N, the receptor for type II FCoV. Thereby, monocytes/macrophages likely 
enhance their own infection rate (Takano et al., 2007a, 2007b). However, in vivo FIP is 
associated with a decrease in TNF-α transcription in lymphatic tissues (Kipar et al., 2006b). 
This was seen in conjunction with increased IL-1β and IL-6 but decreased IL-12 and IL-10 
transcription (Kipar et al., 2006b).  Taken together, those previous studies suggest that other 
cell types are involved in the disease process. In cats with FIP, acute phase proteins produced 
by the liver such as haptoglobin and serum amyloid A, and in particular alpha1-acid 
glycoprotein (AGP), have been shown to be elevated and are often considered key elements of 
the diagnostic process (Duthie et al., 1997; Giordano et al., 2004). In conjunction with 
appropriate clinical signs, raised AGP levels are more effective than effusion analysis or 
serology at discriminating between FIP and other diseases (Giori et al., 2011). This suggests 
more extensive hepatic involvement in the disease. 
The liver is known as a major target for cytokines (Moshage, 1997; Ramadori and Armbrust, 
2001) but a number of studies involving human, rat or murine hepatocytes have shown that 
these cells also produce cytokines, including IL-1, IL-6, IL-10, IL-12, and TNF-α (González-
Amaro et al., 1994;Alfrey et al., 1995; Saad et al., 1995; Frede et al., 1996; Panesar et al., 1999; 
Stonāns et al., 1999; Dikopoulos et al., 2004).  A preliminary immunohistological study 
indicated that in cats with FIP hepatocytes express TNF-α (unpublished data). 
We therefore hypothesised that the liver also contributes to FIP via cytokine production.  To 
evaluate this we measured relative mRNA levels of IL-1β, IL-6, IL-10, IL-12p40, and TNF-α 
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by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and used 




Animals and tissue processing  
The study was undertaken on three groups of cats. Group 1 comprised 16 cats with FIP 
including 12 pet cats (5 months to 2 years) submitted for diagnostic necropsy that had died or 
were euthanased with natural FIP (Group 1a).  A further four cats had been euthanased with 
FIP after experimental intra-peritoneal infection with the serotype I FCoV strain FIPV-UCD 
at the University of Utrecht, The Netherlands (Group 1b).  Approval for this experiment was 
obtained from the Ethical Committee of Utrecht University (approval number: 0502.0802, 
10.10.2005). All showed clinical signs of FIP which necessitated euthanasia of two cats at 3.5 
and 4 weeks post infection (p.i.) whilst the remaining two were euthanased at the end of the 
experiment (11 weeks p.i.).  
For Group 1, the diagnosis of FIP was confirmed by gross, histological, and 
immunohistological examination (Kipar et al., 1998). Cases were split into wet, dry, and mixed 
forms of the disease based on clinical and necropsy findings. 
Group 2 consisted of 14 clinically healthy, male, specific pathogen free (SPF) cats 
euthanased between 14 and 80 days p.i. (Meli et al., 2004) that had been perorally infected at 
an age of 8.5 to 27 weeks with a previously isolated serotype I FCoV field strain of low 
virulence (feline enteric coronavirus; FECV) (Meli et al., 2004). This experiment was 
performed under the Swiss regional legislation (project license number TVB 66/2000; date of 
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approval: 31.07.2001).  All had tested positive for CoV antibodies and circulating FCoV-
specific immune complexes and were confirmed to be systemically FCoV infected by the 
presence of a monocyte-associated FCoV viraemia.  
All animals were necropsied within 30 min of death. Liver samples from grossly normal 
regions were collected and immediately frozen at -80 °C for RNA extraction, or fixed in 10% 
buffered formalin for 24-48 h and routinely paraffin wax embedded for histological and 
immunohistological examination.   
The third group comprised six healthy untreated SPF cats, aged 36-38 months, that had been 
euthanased at the University of Glasgow, UK as part of a study performed under UK Home 
Office Project Licence PPL 60/3735; approved 04.01.2008. From these cats, formalin fixed, 
paraffin embedded liver samples were kindly provided by Prof M Hosie.  
 
Reverse transcription and quantitative polymerase chain reaction (qRT-PCR) for feline 
cytokines   
From each frozen liver sample, approximately 100 mg was taken for RNA extraction and 
subsequent cDNA synthesis, following previously published protocols (Kipar et al., 2006a). 
qRT-PCR for feline IL-1, IL-6, IL-10, IL-12p40, and TNF-α was carried out on the cDNA 
samples, using previously published assays (Table 1a; (Leutenegger et al., 1999; Kipar et al., 
2001b, 2006b)). The levels of the housekeeping gene feline glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) served as internal controls. All reactions were run in duplicate, using 
identical and previously published amplification conditions and assay compositions (Kipar et 




Relative quantification of cytokine transcripts and statistical analysis  
Relative quantification of cytokine signals was done by the comparative CT method and is 
reported as the n-fold difference relative to the fGAPDH cDNA levels for each sample. This 
serves to normalise for differences in the amount of total nucleic acid added to each reaction 
and the efficiency of the reverse transcriptase step as previously described (Kipar et al., 2001a, 
2006a).  The programme Minitab was used for statistical comparison; a two-tailed Mann-
Whitney test was applied at the 95 % confidence level on the premise that cytokine levels in 
the two groups were different.  First the natural FIP (Group 1a) cases were compared with the 
experimental FIP (Group 1b) cases to determine if they could be classed as one group.  As no 
significant difference was found between these subgroups, all of Group 1 was compared to 
Group 2.  Both Group 1a and 1b were also compared separately to Group 2.   
Within Group 1, cytokine mRNA levels from cats with the wet, dry or mixed form were 
compared.  
The IL-12p40:IL-10 mRNA ratio was evaluated using the Independent Samples Median 
Test. 
 
Antibodies specific for feline cytokines  
A panel of rabbit anti-peptide antibodies, specific for feline IL-1, IL-6, IL-10, IL-12p40, 
and TNF-α was commercially produced (Genosphere Biotechnologies, Paris, France). 
Antibodies were raised against the C-terminus of the proteins by using 14 amino acid long 
synthetic peptides with an additional cysteine residue at the N-terminus  coupled to keyhole 
limpet hemocyanin (KLH) carrier (Table 1b). 
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All antisera had been determined by the supplier by ELISA to have a titre greater than 
1:10,000 when tested against the peptide antigen. 
Antibody specificity was confirmed by ELISA and dot blot, using recombinant cytokines 
(recombinant human IL-1β and TNF-α (Peprotech); feline IL-6 (Serotec); feline IL-1β, TNF-α, 
IL-12 (R&D Systems)), following routine protocols. The antibodies were subsequently used in 
immunoblots and immunohistology.  
 
Immunoblots for the detection of feline cytokines in the liver  
Frozen liver samples (100 - 400 mg) from Group 1b were pulverised at 2,000 rpm for 1 min 
in a liquid nitrogen cooled stainless steel chamber according to manufacturer’s 
recommendations (Braun Mikrodismembranator) and dissolved in 2 ml/g lysis buffer (Takeuchi 
et al., 2005) for 30 min at 4 °C. After further centrifugation (3,000 g, 10 min at 4 °C), the 
supernatant was subjected to sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) under non-reducing conditions following routine protocols to confirm the 
presence of proteins of appropriate size. 
Immunoblotting was performed with the recombinant cytokines over a range of 
concentrations (total loading of 0.625 – 100 ng), in addition to the liver samples. The liver 
samples were separated in SDS-PAGE, followed by transfer onto nitrocellulose according to 
standard protocols. After transfer the membrane was incubated in 0.005 % hydrogen peroxide 
in phosphate-buffered saline (PBS) for 30 min to block endogenous peroxidase activity (liver 
homogenates) and in blocking buffer (3 % w/v skimmed milk powder in PBS) for 1 h, followed 
by 15 - 18 h incubation with the primary anti-feline cytokine antibodies (1:500 to 1:10,000 in 
PBS). To confirm that the secondary antibody was not binding feline immunoglobulins present 
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in the liver sample, it was incubated with cat serum prior to its application to the membrane 
(negative controls). 
 
Histopathological examination and immunohistology for feline cytokines 
Formalin-fixed, paraffin embedded liver sections (3 - 5 µm) from animals of each group 
were routinely stained with haematoxylin and eosin for histopathological examination, and a 
selection subjected to immunohistology for feline cytokines using the peroxidase anti-
peroxidase (PAP) method (Kipar et al., 1998), with diaminobenzidine as the chromogen and 
Papanicolaou’s haematoxylin counterstaining (five cats from Group 1a and all four cats from 
Group 1b). 
Sections incubated with rabbit pre-immune serum and/or PBS instead of the primary 
antibody and sections incubated with antibodies blocked by the respective peptide served as 
negative controls.   
Various dilutions and reaction conditions had been tested and assessed histologically; they 
were deemed appropriate when no non-specific staining of collagen and nuclei was seen.  
Sections were assessed independently by two pathologists and staining was graded in a semi-
quantitative manner as negative, weak, moderate or strong, based on the number of positive 




Cytokine transcription in the liver 
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All tested cytokines were detectable in both FCoV-infected cats with and without FIP 
(Groups 1 and 2), and of these in the majority of animals (81 – 100 % depending on the cytokine, 
Table 2).  
Relative transcription levels of all studied cytokines varied between animals in both groups, 
but were significantly higher (P < 0.05) in cats with FIP. However, they also exhibited higher 
variance between individual cats in this group (Fig. 1). Interestingly, the within group variation 
in transcription levels for each cytokine was lower in Group 1b than in Group 1a, and so were 
the transcription levels overall (though not significantly so). Therefore, when comparing Group 
2 with Group 1b alone, a significant difference was only observed for IL-6 (Fig. 1). Similar 
trends within Group 1 were also observed in the IL-12p40:IL-10 mRNA ratio. The ratio was 
overall significantly higher in Group 1 than Group 2 (P = 0.047), and indeed IL-10 levels were 
higher than IL-12 in all Group 2 cats, whereas in half of the Group 1a cats they were lower. 
Group 1b cats were in between, with slightly higher IL-10 levels in all animals. 
An assessment of medians between Group 1 and 2 for each cytokine found the smallest 
quantitative difference for IL-1β and IL-10; mRNA levels being only ~10 fold higher in Group 
1. For IL-12 and TNF-α a close to 100 fold increase was seen. The difference was largest for 
IL-6, the mRNA level of which was nearly 1,000 fold higher in cats with FIP. Interestingly, IL-
6 was also the cytokine that was transcribed at a lower level than all other cytokines in Group 
2 (though not statistically significant) whereas it was on a par with the others in Group 1. IL-6 
was also the only cytokine that varied between the disease form; its transcription was 
significantly higher (P = 0.04; Mann Whitney) in cats with wet FIP than in those with the dry 
or mixed form.   
 
Cytokine translation in the liver 
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Immunoblots performed on Group 1b liver homogenates yielded bands consistent with the 
expected proteins for IL-10 (both an 18kD monomer and the 36kD glycosylated homodimer 
(Tan et al., 1993), IL-12 (both the p40 monomer and the active p30p45 heterodimer (Brunda, 
1994)), and TNF-α (26 kDa non-glycosylated membrane form and the 51 kDa pyramidal trimer 
(Corti et al., 1992; Otto et al., 1997)).  
Immunohistology was used to identify the cells producing the cytokines. The SPF cat livers 
served to assess FCoV-independent constitutive protein expression. Alongside this, all livers 
were examined for any histopathological changes and FIP-specific inflammatory processes 
(Kipar et al., 1998). 
In SPF cat livers were histologically unaltered. Cytokine expression was mainly evident in 
the bile duct epithelium which exhibited variable expression of all cytokines (Fig. 2). There 
was also occasional evidence (i.e. in one or two animals for each cytokine) of very low level 
expression by hepatocytes, represented by a weak, finely granular cytoplasmic staining (Fig. 
2G, I). Furthermore, Kupffer cells in all SPF cats occasionally expressed IL-1β and in two and 
one cat respectively also IL-6 and IL-12 (Fig. 2G). 
The livers of FCoV-infected cats without FIP generally exhibited mild portal lymphocyte 
infiltration as well as occasional small clusters of lymphocytes and scattered individual 
neutrophils within the sinusoids. The cytokine expression pattern and intensity was similar to 
that seen in SPF cats; hepatocytes largely exhibited either no or very weak staining.  
In cats with FIP, the majority of livers exhibited typical lesions, i.e. fibrinosuppurative 
perihepatitis and/or focal to multifocal granulomatous-necrotising lesions. Cytokine expression 
by inflammatory cells was generally weak, but all cytokines were found to be expressed by 
neutrophils and macrophages as well as low numbers of Kupffer cells (Fig. 2H). Hepatocytes 
were found to express all cytokines. This was seen either as a diffuse staining of all hepatocytes 
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(Fig. 2F, H, J) or appeared variable in its intensity between individual cells (Fig. 2B, D). The 
semi-quantitative assessment of cytokine expression and its relation to the transcription levels 
did not provide any evidence of a direct correlation.  
Sections stained with pre-immune sera or PBS in place of the primary antibody did not yield 




The present study is the first to focus on the expression of cytokines in the liver, and in 
particular by hepatocytes, in cats suffering from a systemic inflammatory disease, FIP. The 
panel of cytokines was chosen as FIP is driven by activated monocytes and characterised by 
vascular inflammatory lesions and fever.  
Using a combination of methods to demonstrate cytokine transcription and in situ protein 
expression, we showed that the feline liver produces a range of pro-inflammatory and 
immunomodulatory cytokines, and identified the hepatocytes as a source of these.   
In FIP, the hepatic transcription of IL-1β, IL-6, IL-10, IL-12 and TNF-α was significantly 
upregulated. Interestingly, when comparing natural and experimental FIP, the range of the 
natural cases extended higher. It is possible that the prior SPF status of the experimentally 
infected cats accounts for this as they would not have had previous exposure to circulating 
FCoVs and/or other common infectious pathogens. 
All cytokines appeared to be constitutively expressed also in the liver of SPF cats, where 
immunohistology identified bile duct epithelial cells as the main source, with Kupffer cells 
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contributing as well. In cats with FIP, inflammatory cells within the typical macrophage 
dominated lesions were also found to express cytokines. However, these likely played a minor 
role in the overall hepatic expression, since we extracted RNA from tissue specimens without 
grossly visible FIP lesions and generally found immunohistological evidence of more consistent 
cytokine expression by hepatocytes than by inflammatory cells. The immunohistological 
staining results did not allow an accurate quantification of translation. Neither could we identify  
a direct correlation between mRNA and protein levels. One explanation for both may be the 
different sensitivities of the two methods. Another is the manifold levels of pre- and 
posttranslational regulation to which cytokines are exposed. Taking TNF-α alone, there is 
regulation of RNA at export, post-transcriptional and translational, with multiple mechanisms 
at each stage (Giambelluca et al., 2013). However, our objective was to view in situ cytokine 
expression in cells of the liver. Our results provide strong evidence that hepatocytes play a role 
in the pathogenesis of FIP. This is supported by data from a mouse study showing that 
hepatocytes can produce at least as much IL-6 per cell as macrophages (Panesar et al., 1999). 
Our study did not assess plasma levels of the cytokines so we did not confirm that they enter 
the general circulation but it is likely since other proteins produced by hepatocytes, such as 
APPs, do so and exert a systemic effect (Moshage, 1997).   
IL-1β, IL-6 and TNF-α are the major inflammatory cytokines the release of which from the 
liver in FIP could contribute to the induction of lesions and clinical signs, such as fever, 
capillary leakage and hepatic APP production (Dinarello et al., 1986; Moshage, 1997; 
Dinarello, 2007). Also, the hypoalbuminaemia and weight loss seen in FIP (Paltrinieri et al., 
1998; de Groot-Mijnes et al., 2005; Paltrinieri, 2008) could be due to IL-1β induced decreased 
albumin production to allow for greater APP synthesis, and TNF-α-induced muscle breakdown. 
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IL-6, known to be particularly stimulated by IL-1β and TNF-α (Kent et al., 1998), showed 
the greatest upregulation of the studied cytokines in association with FIP. In wet FIP, significant 
IL-6 activity has been detected in sera and peritoneal exudate cells (Goitsuka et al., 1990). The 
wet, dry, and mixed forms of FIP indicate different disease states with a variable degree of 
vascular permeability (Takano et al., 2011; Pedersen, 2014). IL-6 can induce vascular 
endothelial growth factor (VEGF) production and pulmonary vascular permeability (Loeffler 
et al., 2005; Feurino et al., 2007; Gurkan et al., 2011), and the degree of ascites was found to 
be correlated with serum VEGF levels in cats with FIP (Takano et al., 2011), This could explain, 
via VEGF upregulation, the particularly high hepatic IL-6 transcription levels seen in cats with 
wet FIP in our study. Hepatic IL-6 release could also contribute to the progressive plasma cell 
infiltration seen in older FIP lesions (Kipar et al., 1998; Kipar & Meli, 2014), as IL-6 induces 
the final maturation of B cells into plasma cells (Kishimoto, 1989). 
TNF-α and IL-1β induce expression of adhesion molecules and chemokine production by 
endothelial cells (EC) which induces leukocyte binding (Abbas et al., 2012). In line with this, 
upregulation of β2-integrins was seen on leukocytes from cats with FIP (Olyslaegers et al.., 
2013). Concurrently, TNF-α, IL-1β and IL-6 can also mediate the firm binding of monocytes 
to EC and can be expected to contribute to the destruction of the vascular basal lamina seen in 
FIP phlebitis (Hayashi et al., 1977; Watanabe et al., 1993; Kipar et al., 1998; Kipar et al., 2005), 
as they upregulate matrix metalloproteinase secretion from monocytes (Sarén et al., 1996; 
Robinson et al., 2002). 
The effects of IL-1β include pyrogenicity, stimulation of B cell antibody production, 
endothelial retraction and gap formation, and neutrophilia; again all likely key to the 
pathogenesis of FIP (Weiss and Scott, 1981b; Staruch and Wood, 1983; Dinarello, 1996). 
Interestingly, IL-1β has been shown experimentally to more than double the half-life of IL-6 
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mRNA, and TNF-α had a similar, but less intense effect (Iwasaki et al., 2011). Accordingly, 
IL-1β could have two relevant synergistic effects in FIP; stimulating IL-6 transcription and 
prolonging the lifespan of IL-6 mRNA (Kent et al., 1998), thereby potentiating its effects. 
IL-10, is an anti-inflammatory and immunosuppressive cytokine (de Waal Malefyt et al., 
1991; Buchwald et al., 1999) that inhibits inflammatory cytokine transcription by monocytes 
(de Waal Malefyt et al., 1991), but also complements IL-6 as it can stimulate antibody 
production and, at high concentrations, increases the phagocytic capacity of 
monocytes/macrophages (Buchwald et al., 1999). Increased viral load in monocytes is seen as 
one of the key steps in the development of FIP (Kipar et al., 2006a; Kipar and Meli, 2014) and 
as the virus is capable of inducing IL-1 β and TNF-α in vitro (Goitsuka et al., 1988; Takano et 
al., 2007b) this may contribute to increased production of these inflammatory cytokines and the 
ensuing systemic effects.  
We also found IL-12 upregulation in the liver in association with FIP. The pro-inflammatory 
effects of IL-12 are usually counteracted by IL-10 which attempts to return the immune 
response to homeostatic base levels (Cao et al., 2002). The IL-12:IL-10 ratio has been used as 
a measure of the balance between pro- and anti-inflammatory states in a number of disease 
conditions (Watson et al., 2012). In our study we found an overall higher hepatic IL-12:IL-10 
mRNA ratio in FIP than in healthy FCoV-infected cats. Despite being archetypally pro-
inflammatory, at high concentrations IL-12 can inhibit the immune response and the generation 
of cytotoxic T lymphocytes (Lasarte et al., 1999; Lee et al., 2000). Via interferon-γ-mediated 
Fc receptor upregulation it could induce enhanced macrophage infection (Puddu et al., 1997; 
Mortola et al., 1998). In contrast to the liver, the mesenteric lymph nodes were previously found 
to downregulate IL-12 transcription in FIP (Kipar et al., 2006). It would appear that neither high 
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IL-12 nor high IL-10 are themselves protective and indeed plasmids encoding IL-12 have been 
found to enhance susceptibility to disease in FIPV vaccination studies (Glansbeek et al., 2002).   
 
Conclusions 
This is the first functional study of its kind on the liver in FIP and its potential role in the 
manifestation of disease. Hepatocytes are able to produce inflammatory and immune-
modulatory cytokines (IL-1β, -6, -10, -12, and TNF-α) and these are transcribed at significantly 
higher levels in cats with FIP than in healthy FCoV infected cats.  This may provide a large 
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Table 1. A.  Sequence of PCR primers and TaqMan probes specific for feline cytokines.  A. 
Amino acid sequences used for anti-feline cytokine antibody production. 
 
A. 

































1 Leutenegger et al., 1999; 2Kipar et al., 2001b.  
 
B. 
Cytokine NCBI Acc.-No. Position Amino acid sequence 
IL-1 AAA30814 251-264 Cys-NTKGGQDITDFIME 
IL-6 P41683 191-204 Cys-LRRLEDFLQFSLRA 
IL-10 AAC64708 144-157 Cys-STFSKLQEKGVYKA 
IL-12p40 AAB93835 185-198 Cys-RDYKKYTVECQEGS 




Table 2. Detection of cytokine mRNA transcription in the livers of naturally and experimentally 
infected cats with feline infectious peritonitis (FIP), and of experimentally feline coronavirus 
(FCoV)-infected, healthy cats (FCoV-infected cats without FIP) and results of statistical 
examinations (P values of a two-tailed Mann-Whitney comparison between different groups). 
Cytokine Group 
Group 1 and 2 distribution statistics 
Group comparison 





























































0.0785 0.0168* 0.0043* 0.8734 
No. +ve: number of cases with positive qRT-PCR result; SE: standard error; CI: confidence 
interval; Group 1: all cats with FIP, n = 16; Group 1a: naturally infected cats with FIP (n = 12); 
Group 1b: experimentally infected cats with FIP (n = 4); Group 2: FCoV infected cats without 










Fig. 1. Comparison of relative cytokine transcription levels between cats with feline infectious 
peritonitis (FIP) and healthy, feline coronavirus (FCoV)-infected cats; box and whisker plots 
together with illustration of disease form of individual cats. Group 1a - natural FIP cases; 1b - 
experimentally infected cats with FIP; 2 - FCoV-infected cats without FIP; * - statistically 
significant difference (P < 0.05).  
Boxes indicate the median value and the interquartile range, whilst whiskers indicate the spread 






Fig. 2. Immunohistological staining for the expression of cytokines in the liver. Left column: 
specific pathogen free (SPF) cats; right column: cats with FIP. A, B: Expression of IL-1β. A: 
In SPF cats, expression is restricted to bile duct (B) epithelial cells and the media of small 
arteries (A). V: vein in portal area. B: In a FIP cat, hepatocytes exhibit variably intense 
expression. C, D: Expression of IL-6. C: In SPF cats, expression is restricted to a weak staining 
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in bile duct (B) epithelial cells and the media of small arteries (A). D: In a FIP cat, a large 
proportion of hepatocytes exhibit variably intense expression. V: vein in portal area. E, F: 
Expression of IL-10. E: In SPF cats, expression is restricted to bile duct epithelial cells (arrow). 
A: artery, V: vein in portal area. F: In a FIP cat, hepatocytes exhibit a diffuse strong expression. 
The staining in bile duct epithelial cells (arrow) is even stronger. V: vein in portal area. G, H: 
Expression of IL-12p40. G: In a SPF cat, very weak expression is seen within hepatocytes. 
Occasional positive Kupffer cells (arrow) are also seen. H: In a FIP cat, hepatocytes exhibit a 
diffuse weak to moderate expression. In a granulomatous infiltrate, there are some weakly 
positive macrophages (arrows). I, J: Expression of TNF-α. I: In a SPF cat, very weak expression 
is seen within hepatocytes and bile duct epithelial cells (arrow). J: In a cat with FIP, hepatocytes 
exhibit a diffuse weak staining. Peroxidase anti-peroxidase method, Papanicolaou’s 
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